The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

12 Oct 2017 16:48

RNS Number : 4896T
Ergomed plc
12 October 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Ergomed plc

 

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Type 1 Disclosure as per the Transparency Directive II Regulation

3. Details of person subject to the notification obligationiv

Name

Octopus Investments Nominees Limited

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

11/10/2017

6. Date on which issuer notified (DD/MM/YYYY):

12/10/2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.99%

N/A

6.99%

42,680,813

 

Position of previous notification (if

applicable)

7.00%

N/A

7.00%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BN7ZCY67

2,984,620

6.99%

SUBTOTAL 8. A

2,984,620

6.99%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Octopus Capital Ltd

Octopus Investments Ltd

Octopus Investments Nominees Ltd

6.99%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information N/A

 

Place of completion

33 Holborn, London, EC1N 2HT

Date of completion

12/10/2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLOKBDQPBDDAKD
Date   Source Headline
2nd Jun 20234:48 pmRNSTR1 Notification
26th May 20238:38 amRNSNotice of AGM and Annual Report
19th Apr 20237:00 amRNSDirector's Dealing
17th Apr 20237:00 amRNSHolding(s) in Company
13th Apr 20233:27 pmRNSHoldings in Company
3rd Apr 20239:51 amRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20233:37 pmRNSHolding(s) in Company
21st Mar 20237:00 amRNSErgomed Preliminary Results 2022
17th Mar 202311:39 amRNSHoldings in Company
1st Mar 20237:07 amRNSTotal Voting Rights
16th Feb 20231:44 pmRNSHolding(s) in Company
14th Feb 20237:01 amRNSNotice of Preliminary Results
1st Feb 20237:00 amRNSTotal Voting Rights
25th Jan 20237:00 amRNSJonathan Curtain appointed CFO
25th Jan 20237:00 amRNSErgomed 2022 Trading Update
20th Jan 20235:23 pmRNSHolding(s) in Company
20th Jan 20239:38 amRNSHolding(s) in Company
3rd Jan 20237:00 amRNSTotal Voting Rights and Block Listing Return
5th Dec 20227:00 amRNSDirector Dealings
2nd Dec 20227:00 amRNSJohn Dawson appointed Senior Independent Director
1st Dec 20227:00 amRNSTotal Voting Rights
22nd Nov 20227:00 amRNSExercise of Share Options and Total Voting Rights
21st Nov 202210:46 amEQSErgomed (ERGO): Two key management changes
17th Nov 20227:00 amRNSErgomed Strengthens Executive Management Team
16th Nov 20227:00 amRNSExercise of Share Options and Total Voting Rights
1st Nov 20224:16 pmRNSExercise of Share Options and Total Voting Rights
1st Nov 20227:00 amRNSTotal Voting Rights
20th Oct 20222:09 pmRNSHolding(s) in Company
14th Oct 20224:09 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSHolding(s) in Company
4th Oct 202212:52 pmEQSErgomed (ERGO): Poised for a strong FY22
3rd Oct 20227:00 amRNSTotal Voting Rights
27th Sep 20227:00 amRNSErgomed Interim results 2022
2nd Sep 20227:00 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSErgomed Notice of Results
19th Aug 20222:49 pmRNSHolding(s) in Company
1st Aug 20228:10 amEQSErgomed (ERGO): Sustained growth momentum in H122
1st Aug 20227:00 amRNSDirector Dealing
1st Aug 20227:00 amRNSTotal Voting Rights
26th Jul 20227:00 amRNSErgomed H1 2022 Trading Update
1st Jul 20227:00 amRNSTotal Voting Rights and Block Listing Return
10th Jun 202211:21 amRNSResults of 2022 Annual General Meeting
10th Jun 20227:00 amRNSErgomed Annual General Meeting Statement
10th Jun 20227:00 amRNSAnne Whitaker appointed to the Board as NED
1st Jun 20227:00 amRNSErgomed plc Total Voting Rights
13th May 20227:00 amRNSErgomed Notice of AGM and Annual Report
3rd May 20228:49 amRNSErgomed plc Total Voting Rights
28th Apr 20227:01 amEQSErgomed (ERGO): Healthy fundamentals for 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.